| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
63,220 |
57,427 |
$3.64M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
14,231 |
13,291 |
$1.82M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
10,116 |
9,070 |
$1.49M |
| 81003 |
|
20,429 |
19,042 |
$1.41M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
24,540 |
20,922 |
$1.35M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,788 |
13,418 |
$895K |
| 80053 |
Comprehensive metabolic panel |
17,600 |
15,655 |
$792K |
| 36415 |
Collection of venous blood by venipuncture |
12,984 |
10,956 |
$749K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
11,242 |
9,671 |
$545K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
32,555 |
29,612 |
$479K |
| 81025 |
|
18,233 |
16,962 |
$431K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,612 |
2,395 |
$417K |
| 81001 |
|
10,094 |
9,306 |
$350K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
18,521 |
16,161 |
$336K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,299 |
2,110 |
$309K |
| 87210 |
|
4,115 |
3,474 |
$291K |
| 87430 |
|
4,757 |
4,434 |
$274K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,569 |
5,259 |
$245K |
| 73630 |
|
2,488 |
2,344 |
$241K |
| 71046 |
Radiologic examination, chest; 2 views |
8,487 |
7,969 |
$237K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,774 |
1,618 |
$230K |
| 73610 |
|
2,010 |
1,882 |
$214K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
6,554 |
1,092 |
$214K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,014 |
4,685 |
$205K |
| 73130 |
|
1,551 |
1,437 |
$192K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,545 |
2,450 |
$181K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,702 |
2,552 |
$180K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,931 |
3,437 |
$173K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
361 |
352 |
$168K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,676 |
867 |
$145K |
| 87081 |
|
4,509 |
3,883 |
$133K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,372 |
1,125 |
$124K |
| 87077 |
|
6,365 |
5,614 |
$111K |
| 71045 |
Radiologic examination, chest; single view |
10,734 |
9,632 |
$111K |
| 73030 |
|
1,699 |
1,593 |
$111K |
| J7050 |
Infusion, normal saline solution, 250 cc |
495 |
413 |
$110K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
402 |
386 |
$107K |
| 73562 |
|
1,477 |
1,362 |
$106K |
| 73110 |
|
957 |
914 |
$99K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
14,745 |
13,294 |
$97K |
| 73140 |
|
538 |
516 |
$93K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
132 |
126 |
$91K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,867 |
2,502 |
$90K |
| J3490 |
Unclassified drugs |
491 |
341 |
$88K |
| 84702 |
|
2,135 |
1,785 |
$84K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,287 |
2,161 |
$80K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,596 |
5,773 |
$79K |
| 71250 |
|
429 |
407 |
$76K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,170 |
2,850 |
$75K |
| 87147 |
|
1,160 |
825 |
$71K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,819 |
1,712 |
$70K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,677 |
5,280 |
$70K |
| 84132 |
|
1,982 |
1,768 |
$67K |
| A0425 |
Ground mileage, per statute mile |
4,887 |
3,667 |
$66K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,853 |
1,541 |
$63K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
769 |
646 |
$61K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,055 |
983 |
$59K |
| 73560 |
|
956 |
929 |
$57K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
60 |
53 |
$57K |
| 72100 |
|
1,513 |
1,453 |
$57K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
657 |
620 |
$56K |
| 87070 |
|
4,082 |
3,453 |
$56K |
| 84484 |
|
10,891 |
8,730 |
$56K |
| 86900 |
|
3,394 |
2,986 |
$53K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,002 |
4,379 |
$51K |
| 86901 |
|
3,396 |
2,987 |
$45K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
75 |
69 |
$45K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,039 |
1,008 |
$44K |
| 73502 |
|
1,196 |
1,116 |
$44K |
| 93971 |
|
257 |
248 |
$38K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
27,632 |
23,632 |
$37K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
414 |
373 |
$35K |
| 86850 |
|
2,953 |
2,597 |
$35K |
| 87040 |
|
2,692 |
2,155 |
$35K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
665 |
642 |
$32K |
| 85027 |
|
14,445 |
12,730 |
$32K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
5,703 |
5,308 |
$30K |
| 85610 |
|
3,794 |
3,338 |
$30K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
254 |
243 |
$28K |
| 87428 |
|
151 |
144 |
$27K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
2,985 |
2,138 |
$25K |
| 97597 |
|
465 |
300 |
$23K |
| 80076 |
|
4,130 |
3,870 |
$23K |
| 96376 |
|
2,075 |
1,516 |
$22K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
87 |
77 |
$20K |
| 87075 |
|
606 |
551 |
$19K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,241 |
4,024 |
$18K |
| 74018 |
|
364 |
338 |
$16K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
167 |
116 |
$16K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,349 |
7,314 |
$15K |
| 85379 |
|
3,133 |
2,942 |
$14K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
983 |
931 |
$14K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,714 |
4,482 |
$13K |
| 72141 |
|
26 |
26 |
$13K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
16,483 |
14,537 |
$12K |
| C1769 |
Guide wire |
1,084 |
975 |
$12K |
| 97161 |
|
692 |
639 |
$12K |
| 95800 |
|
66 |
66 |
$10K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
101 |
98 |
$9K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
927 |
830 |
$9K |
| 80061 |
Lipid panel |
4,029 |
3,845 |
$8K |
| 88304 |
|
173 |
167 |
$8K |
| G0378 |
Hospital observation service, per hour |
3,316 |
1,995 |
$7K |
| 84439 |
|
1,350 |
1,294 |
$7K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
128 |
123 |
$6K |
| 82550 |
|
2,146 |
2,013 |
$6K |
| 83605 |
|
4,191 |
3,650 |
$6K |
| 76830 |
Ultrasound, transvaginal |
51 |
51 |
$5K |
| 93458 |
|
26 |
24 |
$5K |
| 12001 |
|
163 |
155 |
$5K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
121 |
98 |
$5K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
648 |
596 |
$3K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
242 |
234 |
$3K |
| 74019 |
|
151 |
147 |
$3K |
| 10061 |
|
367 |
345 |
$3K |
| 82570 |
|
471 |
435 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,767 |
3,185 |
$3K |
| 87205 |
|
850 |
753 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,006 |
977 |
$2K |
| 10060 |
|
123 |
117 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30 |
28 |
$2K |
| 72050 |
|
46 |
43 |
$2K |
| 87481 |
|
13 |
13 |
$2K |
| 73590 |
|
16 |
15 |
$2K |
| 0240U |
|
13 |
12 |
$2K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
26 |
24 |
$2K |
| 86140 |
|
266 |
213 |
$2K |
| 73090 |
|
25 |
24 |
$2K |
| 83880 |
|
4,154 |
3,707 |
$1K |
| 77080 |
|
12 |
12 |
$1K |
| 83690 |
|
9,006 |
8,242 |
$1K |
| 83735 |
|
6,293 |
5,227 |
$1K |
| 86592 |
|
179 |
163 |
$1K |
| 82728 |
|
527 |
495 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
766 |
577 |
$917.44 |
| 97165 |
|
295 |
274 |
$882.28 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
175 |
118 |
$828.99 |
| J2704 |
Injection, propofol, 10 mg |
2,215 |
1,144 |
$798.72 |
| 72072 |
|
15 |
13 |
$720.67 |
| 83540 |
|
323 |
299 |
$685.49 |
| 73070 |
|
13 |
13 |
$644.38 |
| 70491 |
|
13 |
12 |
$593.34 |
| 82607 |
|
303 |
283 |
$579.25 |
| 87186 |
|
3,193 |
2,834 |
$455.89 |
| 82785 |
|
41 |
38 |
$415.65 |
| A9270 |
Non-covered item or service |
7,584 |
5,631 |
$391.69 |
| 72131 |
|
58 |
53 |
$385.19 |
| 80164 |
|
83 |
78 |
$267.78 |
| 70486 |
|
14 |
13 |
$225.01 |
| 83021 |
|
30 |
27 |
$194.68 |
| 90715 |
|
1,189 |
1,136 |
$189.61 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
38 |
24 |
$167.67 |
| 82950 |
|
92 |
90 |
$160.64 |
| 85660 |
|
33 |
29 |
$127.88 |
| 87807 |
|
16 |
16 |
$125.41 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
842 |
772 |
$115.92 |
| 87150 |
|
1,603 |
1,468 |
$112.05 |
| 84156 |
|
89 |
79 |
$66.02 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
243 |
223 |
$50.26 |
| 85730 |
|
930 |
818 |
$46.85 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
291 |
272 |
$37.25 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,186 |
3,576 |
$29.95 |
| 85652 |
|
195 |
180 |
$29.62 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,083 |
913 |
$24.82 |
| 82043 |
|
42 |
39 |
$4.21 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
313 |
291 |
$4.17 |
| 85014 |
|
52 |
43 |
$0.00 |
| 76937 |
|
238 |
221 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
128 |
109 |
$0.00 |
| 99152 |
|
131 |
109 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
539 |
468 |
$0.00 |
| 82009 |
|
113 |
103 |
$0.00 |
| 84145 |
|
149 |
137 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
136 |
122 |
$0.00 |
| 29125 |
|
77 |
76 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
68 |
55 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
192 |
122 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
662 |
450 |
$0.00 |
| 86787 |
|
33 |
28 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
170 |
92 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
136 |
108 |
$0.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
12 |
12 |
$0.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
16 |
14 |
$0.00 |
| C1776 |
Joint device (implantable) |
15 |
13 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
27 |
25 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
12 |
12 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
12 |
12 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
25 |
25 |
$0.00 |
| 64447 |
|
25 |
25 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
58 |
50 |
$0.00 |
| 84100 |
|
64 |
45 |
$0.00 |
| 12011 |
|
25 |
25 |
$0.00 |
| 93976 |
|
14 |
13 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
50 |
43 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,659 |
1,498 |
$0.00 |
| A0888 |
Noncovered ambulance mileage, per mile (e.g., for miles traveled beyond closest appropriate facility) |
51 |
47 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
907 |
773 |
$0.00 |
| 87340 |
|
85 |
77 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,141 |
1,886 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,378 |
1,249 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
136 |
127 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,175 |
1,016 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
59 |
59 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
279 |
176 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
199 |
171 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
238 |
197 |
$0.00 |
| 97535 |
Self-care/home management training, each 15 minutes |
15 |
13 |
$0.00 |
| 87184 |
|
14 |
12 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
54 |
41 |
$0.00 |
| 83550 |
|
186 |
167 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
497 |
448 |
$0.00 |
| 36000 |
|
27 |
26 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
40 |
38 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
41 |
24 |
$0.00 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
129 |
126 |
$0.00 |
| 88342 |
|
25 |
25 |
$0.00 |
| 86747 |
|
34 |
29 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
98 |
80 |
$0.00 |
| 86762 |
|
31 |
26 |
$0.00 |
| 84703 |
|
38 |
38 |
$0.00 |
| 85018 |
|
71 |
59 |
$0.00 |
| 84153 |
|
13 |
13 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
17 |
14 |
$0.00 |
| 64450 |
|
13 |
13 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
14 |
13 |
$0.00 |